BIOMAT Database Logo BIOMAT Database Logo

[Extended spectrum beta-lactamases]. 1993

A Philippon, and G Arlet, and P Lagrange
Hôpital Saint-Louis, service de bactériologie-virologie hygiène, Paris.

At least 30 extended-spectrum beta-lactamases (ESB) have emerged responsible for resistance to indigestible beta-lactams (C3G) since their discovery in West Germany in 1983. Most of them are produced by enterobacteria and essentially K. pneumoniae which appeared susceptible to oxyimino-beta-lactams. A double-disk test was useful to detect such nosocomial isolates of enterobacteria (urines, blood, wound, sputum cultures) mostly recovered from patients in intensive care units. These have spread through hospital and outbreaks were described. Because plasmid-encoded this resistance mechanism was spreading among enterobacteria with other resistance markers (e.g. netilmicin, amikacin). It seems highly likely that the use of newer antibiotics favors the appearance of ESB obtained by selection of mutated genes coding for penicillinases (TEM, SHV). Treatment including a beta-lactam is still possible because of the stability of some beta-lactams e.g. cefamycins, carbapenems and the sensitivity to beta-lactam inhibitors. Digestive selective decontamination may overcome outbreak.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D004756 Enterobacteriaceae Infections Infections with bacteria of the family ENTEROBACTERIACEAE. Enterobacterial Infections,Cronobacter Infections,Infections, Enterobacteriaceae,Infections, Enterobacterial,Cronobacter Infection,Enterobacteriaceae Infection,Enterobacterial Infection,Infection, Cronobacter,Infection, Enterobacteriaceae,Infection, Enterobacterial,Infections, Cronobacter
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases

Related Publications

A Philippon, and G Arlet, and P Lagrange
Extended-spectrum beta-lactamases.
September 2001, Seminars in respiratory infections,
A Philippon, and G Arlet, and P Lagrange
Extended-spectrum beta-lactamases.
February 2003, Seminars in respiratory and critical care medicine,
A Philippon, and G Arlet, and P Lagrange
Extended-spectrum beta-lactamases.
August 1989, Antimicrobial agents and chemotherapy,
A Philippon, and G Arlet, and P Lagrange
Extended spectrum beta-lactamases.
May 1998, The Journal of infection,
A Philippon, and G Arlet, and P Lagrange
Extended-spectrum beta-lactamases.
September 2002, Seminars in respiratory infections,
A Philippon, and G Arlet, and P Lagrange
Extended-spectrum beta-lactamases.
December 2000, Seminars in respiratory infections,
A Philippon, and G Arlet, and P Lagrange
Extended-spectrum beta-lactamases.
August 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Philippon, and G Arlet, and P Lagrange
Extended-spectrum beta-lactamases (ESBL).
January 2002, Connecticut medicine,
A Philippon, and G Arlet, and P Lagrange
More extended-spectrum beta-lactamases.
September 1991, Antimicrobial agents and chemotherapy,
A Philippon, and G Arlet, and P Lagrange
Minor extended-spectrum beta-lactamases.
January 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Copied contents to your clipboard!